AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34534353 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-food/well-formulated ketogenic diet (WFKD)
Number of subjects: 0
Study 34534353 — intervention group
Group type: COMPARATOR
Intervention: Minimally processed whole-food diet (WFD)
Number of subjects: 0
Study 34035871 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity Pulsed Ultrasound (LIPUS) applied at 1.1 MHz frequency and 30 mW/cm2 intensity output for 20 minutes extraorally, reapplied after 3 weeks for 2 more visits.
Number of subjects: 22
Study 34035871 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no LIPUS treatment).
Number of subjects: 22
Study 34035871 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity Pulsed Ultrasound (LIPUS) treatment.
Number of subjects: 22
Study 32059021 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized strategy
Number of subjects: 903
Study 32059021 — intervention group
Group type: COMPARATOR
Intervention: Open strategy
Number of subjects: 903
Study 36252718 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (24 mg intravenously, perioperatively)
Number of subjects: 290
Study 36252718 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone and Placebo
Number of subjects: 290
Study 34472755 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiaoshen needling (acupuncture or electroacupuncture at Baihui (GV20), Shenting (GV24), Yintang (GV29), bilateral Shenmen (HT7), and Sanyinjiao (SP6))
Number of subjects: 60
Study 34472755 — intervention group
Group type: COMPARATOR
Intervention: Control group (acupuncture or electroacupuncture at bilateral Shousanli (LI10), Futu (ST32), and Feiyang (BL58))
Number of subjects: 60
Study 36175281 — intervention group
Group type: EXPERIMENTAL
Intervention: Target Saturation Biopsy (TS) with nine cores
Number of subjects: 170
Study 36175281 — intervention group
Group type: COMPARATOR
Intervention: Conventional Targeted Biopsy (TB) with four cores
Number of subjects: 170
Study 36175281 — intervention group
Group type: EXPERIMENTAL
Intervention: Target Saturation Biopsy (TS)
Number of subjects: 170
Study 36175281 — intervention group
Group type: COMPARATOR
Intervention: Conventional Targeted Biopsy (TB)
Number of subjects: 170
Study 32690432 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted serum iron (1-SD increase)
Number of subjects: 48972
Study 32690147 — intervention group
Group type: EXPERIMENTAL
Intervention: Sesame-canola oil
Number of subjects: 168
Study 32690147 — intervention group
Group type: EXPERIMENTAL
Intervention: Canola oil
Number of subjects: 168
Study 32690147 — intervention group
Group type: EXPERIMENTAL
Intervention: Canola oil and sesame-canola oils
Number of subjects: 168
Study 32690147 — intervention group
Group type: EXPERIMENTAL
Intervention: Sesame oil
Number of subjects: 168
Study 33902652 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietitian adherence to a written nutrition plan
Number of subjects: 194
Study 33902652 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietitian adherence to behaviour change counselling
Number of subjects: 194
Study 33902652 — intervention group
Group type: EXPERIMENTAL
Intervention: Competence in delivering behaviour change counselling
Number of subjects: 194
Study 33455457 — intervention group
Group type: EXPERIMENTAL
Intervention: 25-minutes high-intensity intervals (10, one-minute intervals at 85-90% heart-rate reserve)
Number of subjects: 9
Study 33455457 — intervention group
Group type: EXPERIMENTAL
Intervention: 45-minutes of moderate-intensity exercise (at 50-60% heart-rate reserve)
Number of subjects: 9
Study 33455457 — intervention group
Group type: COMPARATOR
Intervention: Control condition (30-minutes quiet rest)
Number of subjects: 9
Study 32618207 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal therapy (MT)
Number of subjects: 105
Study 32618207 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (CT)
Number of subjects: 105
Study 32618207 — intervention group
Group type: COMPARATOR
Intervention: Standard aerobic training (AT)
Number of subjects: 105
Study 35319652 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2020 (COVID-19 pandemic)
Number of subjects: 2
Study 35319652 — intervention group
Group type: COMPARATOR
Intervention: Group 2019 (pre-COVID-19 pandemic)
Number of subjects: 2
Study 33245746 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg BID
Number of subjects: 1220
Study 33245746 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1220
Study 33245746 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg BID
Number of subjects: 1220
Study 33245746 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall Cohort (Tofacitinib 10 mg BID predominantly)
Number of subjects: 1220
Study 36136830 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-adolescent treatment group
Number of subjects: 225
Study 36136830 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent only treatment group
Number of subjects: 225
Study 36136830 — intervention group
Group type: COMPARATOR
Intervention: Self-study control group
Number of subjects: 225
Study 36136830 — intervention group
Group type: COMPARATOR
Intervention: No treatment control group
Number of subjects: 225
Study 34831759 — intervention group
Group type: EXPERIMENTAL
Intervention: Developmental Network (DN) coaching
Number of subjects: 220
Study 34831759 — intervention group
Group type: COMPARATOR
Intervention: NCR algorithm
Number of subjects: 220
Study 35832268 — intervention group
Group type: EXPERIMENTAL
Intervention: Opaganib
Number of subjects: 42
Study 35832268 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 32390072 — intervention group
Group type: EXPERIMENTAL
Intervention: Ospemifene plus standard of care (SoC)
Number of subjects: 0
Study 32390072 — intervention group
Group type: EXPERIMENTAL
Intervention: Ospemifene
Number of subjects: 0
Study 32390072 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SoC) alone
Number of subjects: 0
Study 32520346 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat dairy (LF) group incorporated ≥3 servings/d of LF dairy
Number of subjects: 111
Study 32520346 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat dairy (HF) group incorporated ≥3 servings/d of HF dairy
Number of subjects: 111
Study 32520346 — intervention group
Group type: COMPARATOR
Intervention: Control group maintained baseline dairy intake
Number of subjects: 111
Study 35389487 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3-PUFA ethyl esters (3.9 g/d)
Number of subjects: 54
Study 35389487 — intervention group
Group type: COMPARATOR
Intervention: Placebo (corn oil)
Number of subjects: 54
Study 33434676 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftolozane/tazobactam 3 g q8h
Number of subjects: 117
Study 33434676 — intervention group
Group type: COMPARATOR
Intervention: Meropenem 1 g q8h
Number of subjects: 117
Study 33434676 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftolozane/tazobactam
Number of subjects: 117
Study 33434676 — intervention group
Group type: COMPARATOR
Intervention: Meropenem
Number of subjects: 117
Study 32739862 — intervention group
Group type: EXPERIMENTAL
Intervention: SCST + TAU
Number of subjects: 47
Study 32739862 — intervention group
Group type: COMPARATOR
Intervention: TAU only
Number of subjects: 47
Study 35587064 — intervention group
Group type: EXPERIMENTAL
Intervention: McKenzie exercises
Number of subjects: 55
Study 35587064 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep neck flexor (DNF) combined with scapulothoracic exercises
Number of subjects: 55
Study 35587064 — intervention group
Group type: COMPARATOR
Intervention: Traditional physical therapy (control)
Number of subjects: 55
Study 34243100 — intervention group
Group type: EXPERIMENTAL
Intervention: Connect for Kinship Parents (Connect-KP)
Number of subjects: 26
Study 34243100 — intervention group
Group type: COMPARATOR
Intervention: care-as-usual (CAU)
Number of subjects: 26
Study 35178664 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 33754453 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT; n=77)
Number of subjects: 213
Study 33754453 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate Continuous Training (MCT; n=63)
Number of subjects: 213
Study 33754453 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommendation of Regular Exercise (RRE; n=73)
Number of subjects: 213
Study 32656865 — intervention group
Group type: EXPERIMENTAL
Intervention: CART model
Number of subjects: 512
Study 32656865 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model
Number of subjects: 512
Study 36214157 — intervention group
Group type: EXPERIMENTAL
Intervention: Somofilcon-A
Number of subjects: 28
Study 36214157 — intervention group
Group type: EXPERIMENTAL
Intervention: Omafilcon-A
Number of subjects: 28
Study 36214157 — intervention group
Group type: COMPARATOR
Intervention: Somofilcon-A and Omafilcon-A
Number of subjects: 28
Study 33932520 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine supplementation
Number of subjects: 0
Study 33932520 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 32040038 — intervention group
Group type: EXPERIMENTAL
Intervention: Bundled rapid HIV and HCV tests with immediate results on-site
Number of subjects: 162
Study 32040038 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (referrals to onsite or off-site laboratory-based HIV and HCV testing with delayed results)
Number of subjects: 162
Study 34332028 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 2400 mg/day and working memory training for 25 days
Number of subjects: 38
Study 34332028 — intervention group
Group type: COMPARATOR
Intervention: Placebo with working memory training for 25 days
Number of subjects: 38
Study 32368942 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic bandage treatment
Number of subjects: 65
Study 32368942 — intervention group
Group type: COMPARATOR
Intervention: Cast immobilization
Number of subjects: 65
Study 36315948 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tenecteplase
Number of subjects: 0
Study 36315948 — intervention group
Group type: COMPARATOR
Intervention: Alteplase
Number of subjects: 0
Study 33135094 — intervention group
Group type: COMPARATOR
Intervention: Case detection strategies using the COPD Diagnostic Questionnaire (CDQ) at 3-year intervals
Number of subjects: 0
Study 33135094 — intervention group
Group type: COMPARATOR
Intervention: All 16 case detection strategies
Number of subjects: 0
Study 33135094 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for smoking cessation and guideline-based inhaler pharmacotherapy for newly diagnosed patients
Number of subjects: 0
Study 33946648 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency dTMS
Number of subjects: 22
Study 33946648 — intervention group
Group type: COMPARATOR
Intervention: Low frequency dTMS
Number of subjects: 22
Study 33946648 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 22
Study 35075598 — intervention group
Group type: EXPERIMENTAL
Intervention: MTA
Number of subjects: 63
Study 35075598 — intervention group
Group type: EXPERIMENTAL
Intervention: LLLT-MTA (Low Level Laser Therapy with MTA)
Number of subjects: 63
Study 35075598 — intervention group
Group type: EXPERIMENTAL
Intervention: DL-MTA (High Power Diode Laser with MTA)
Number of subjects: 63
Study 35416730 — intervention group
Group type: EXPERIMENTAL
Intervention: E-contact intervention
Number of subjects: 170
Study 35416730 — intervention group
Group type: COMPARATOR
Intervention: Intrgroup interaction (control)
Number of subjects: 170
Study 34067389 — intervention group
Group type: EXPERIMENTAL
Intervention: Nature video viewing during exercise period
Number of subjects: 18
Study 34067389 — intervention group
Group type: EXPERIMENTAL
Intervention: Nature video viewing during recovery period
Number of subjects: 18
Study 34067389 — intervention group
Group type: COMPARATOR
Intervention: Black screen during exercise period
Number of subjects: 18
Study 34067389 — intervention group
Group type: COMPARATOR
Intervention: Black screen during recovery period
Number of subjects: 18
Study 35804354 — intervention group
Group type: EXPERIMENTAL
Intervention: Veteran Sponsorship Initiative (VSI)
Number of subjects: 630
Study 32703779 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirfenidone plus inhaled N-acetylcysteine 352.4 mg twice daily
Number of subjects: 81
Study 32703779 — intervention group
Group type: COMPARATOR
Intervention: Pirfenidone alone
Number of subjects: 81
Study 32703779 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirfenidone plus inhaled N-acetylcysteine
Number of subjects: 81
Study 32221490 — intervention group
Group type: EXPERIMENTAL
Intervention: ART with high viscosity GIC
Number of subjects: 154
Study 32221490 — intervention group
Group type: COMPARATOR
Intervention: Composite restoration
Number of subjects: 154
Study 36343758 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium Respimat® 5 μg
Number of subjects: 0
Study 36343758 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34601232 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate cardiovascular exercise (150 min/week, 30 min/day for 5 days a week for 6 months)
Number of subjects: 28
Study 34601232 — intervention group
Group type: COMPARATOR
Intervention: Relaxation exercises (20 min at least five times per week for 6 months)
Number of subjects: 28
Study 32782200 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemoradiotherapy (CRT)
Number of subjects: 217
Study 32782200 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant chemotherapy alone (CTx)
Number of subjects: 217
Study 32782200 — intervention group
Group type: COMPARATOR
Intervention: No adjuvant therapy (noTx)
Number of subjects: 217
Study 32782200 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemoradiotherapy (CRT) with radiation dose ≥54 Gy
Number of subjects: 217
Study 35656822 — intervention group
Group type: EXPERIMENTAL
Intervention: Vericiguat
Number of subjects: 5050
Study 35656822 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5050
Study 34818479 — intervention group
Group type: EXPERIMENTAL
Intervention: Preimplantation genetic testing for aneuploidy (PGT‐A)
Number of subjects: 1212
Study 34818479 — intervention group
Group type: COMPARATOR
Intervention: Conventional in vitro fertilization (IVF)
Number of subjects: 1212
Study 34818479 — intervention group
Group type: EXPERIMENTAL
Intervention: PGT‐A
Number of subjects: 1212
Study 34818479 — intervention group
Group type: COMPARATOR
Intervention: Conventional IVF
Number of subjects: 1212
Study 34818479 — intervention group
Group type: EXPERIMENTAL
Intervention: PGT‐A and Conventional IVF
Number of subjects: 1212
Study 36108766 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple falls (32 participants)
Number of subjects: 428
Study 36108766 — intervention group
Group type: COMPARATOR
Intervention: No falls (299 participants)
Number of subjects: 428
Study 36108766 — intervention group
Group type: EXPERIMENTAL
Intervention: Single fall
Number of subjects: 428
Study 32910450 — intervention group
Group type: EXPERIMENTAL
Intervention: sos training (care as usual plus sos training)
Number of subjects: 250
Study 32910450 — intervention group
Group type: COMPARATOR
Intervention: care as usual (control group)
Number of subjects: 250
Study 36151016 — intervention group
Group type: EXPERIMENTAL
Intervention: L-PRF
Number of subjects: 15
Study 36151016 — intervention group
Group type: COMPARATOR
Intervention: Control (no L-PRF)
Number of subjects: 15
Study 32926117 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Low-Level Light Therapy (LLLT)
Number of subjects: 68
Study 32926117 — intervention group
Group type: COMPARATOR
Intervention: Sham Therapy
Number of subjects: 68
Study 35544437 — intervention group
Group type: EXPERIMENTAL
Intervention: Altruism-eliciting short animated video intervention
Number of subjects: 1373
Study 35544437 — intervention group
Group type: COMPARATOR
Intervention: Text-based intervention focused on non-vaccine-related COVID-19 preventive health measures
Number of subjects: 1373
Study 32348081 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% hydrogen peroxide
Number of subjects: 85
Study 32348081 — intervention group
Group type: COMPARATOR
Intervention: 50% trichloroacetic acid
Number of subjects: 85
Study 32163834 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Number of subjects: 73
Study 32163834 — intervention group
Group type: EXPERIMENTAL
Intervention: Device-guided slow breathing
Number of subjects: 73
Study 32163834 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 73
Study 34346134 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobilization protocol applied on the 0th postoperative day
Number of subjects: 42
Study 34108181 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab + Radium-223
Number of subjects: 45
Study 32084142 — intervention group
Group type: COMPARATOR
Intervention: IFN Nebulization 2 (2 μg/kg)
Number of subjects: 0
Study 32084142 — intervention group
Group type: COMPARATOR
Intervention: IFN Nebulization 1 (1 μg/kg)
Number of subjects: 0
Study 32084142 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 36471382 — intervention group
Group type: EXPERIMENTAL
Intervention: Teleconsultations by specialists for neurology and palliative medicine
Number of subjects: 0
Study 36471382 — intervention group
Group type: COMPARATOR
Intervention: Control group with interventions after a 12-month delay
Number of subjects: 0
Study 33879349 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma MMP‐2
Number of subjects: 387
Study 33879349 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma MMP‐9
Number of subjects: 387
Study 35557247 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin
Number of subjects: 38
Study 35557247 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 32819321 — intervention group
Group type: EXPERIMENTAL
Intervention: dorsomedial prefrontal intermittent theta burst stimulation (iTBS)
Number of subjects: 0
Study 32819321 — intervention group
Group type: COMPARATOR
Intervention: sham treatment
Number of subjects: 0
Study 33957713 — intervention group
Group type: EXPERIMENTAL
Intervention: Steam bath intervention (10-15 min session once a week for 12 weeks)
Number of subjects: 40
Study 34462030 — intervention group
Group type: EXPERIMENTAL
Intervention: Unipolar mania
Number of subjects: 80
Study 34462030 — intervention group
Group type: COMPARATOR
Intervention: Bipolar disorder
Number of subjects: 80
Study 33769573 — intervention group
Group type: EXPERIMENTAL
Intervention: FAR angle measurement in CSP
Number of subjects: 15
Study 33769573 — intervention group
Group type: COMPARATOR
Intervention: FAR angle measurement in normal pregnancies
Number of subjects: 15
Study 33769573 — intervention group
Group type: EXPERIMENTAL
Intervention: ROC curve analysis for FAR angle
Number of subjects: 15
Study 33574009 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mL LR-PRP injection (single dose)
Number of subjects: 60
Study 33574009 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mL LR-PRP injection (double dose)
Number of subjects: 60
Study 33574009 — intervention group
Group type: COMPARATOR
Intervention: Both groups (single and double dose)
Number of subjects: 60
Study 36181292 — intervention group
Group type: EXPERIMENTAL
Intervention: 308 nm excimer laser
Number of subjects: 21
Study 36181292 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% tacrolimus
Number of subjects: 21
Study 34615756 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary decompressive craniectomy (DC)
Number of subjects: 0
Study 34615756 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary decompressive craniectomy (DC)
Number of subjects: 0
Study 32799871 — intervention group
Group type: EXPERIMENTAL
Intervention: Videos with non-native English accent (NNEA)
Number of subjects: 42
Study 32799871 — intervention group
Group type: COMPARATOR
Intervention: Videos without non-native English accent
Number of subjects: 42
Study 35339102 — intervention group
Group type: EXPERIMENTAL
Intervention: 700/35 mg foslevodopa/foscarbidopa subcutaneous infusion over 24 h
Number of subjects: 25
Study 35339102 — intervention group
Group type: COMPARATOR
Intervention: 350/87.5 mg LD/CD administered over 16 h followed by two 100/25 mg LD/CD oral doses
Number of subjects: 25
Study 33492637 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma (CP) therapy
Number of subjects: 0
Study 32558416 — intervention group
Group type: EXPERIMENTAL
Intervention: UDCA 5 mg/kg/dose every 12 hours orally with phototherapy
Number of subjects: 120
Study 32558416 — intervention group
Group type: EXPERIMENTAL
Intervention: UDCA 7.5 mg/kg/dose every 12 hours orally with phototherapy
Number of subjects: 120
Study 32558416 — intervention group
Group type: COMPARATOR
Intervention: Placebo with phototherapy
Number of subjects: 120
Study 32517477 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (weekly for five consecutive weeks)
Number of subjects: 70
Study 32517477 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (pre-treatment effect)
Number of subjects: 70
Study 32517477 — intervention group
Group type: COMPARATOR
Intervention: Control group (late intervention with 6-week delay)
Number of subjects: 70
Study 33271482 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 20
Study 33271482 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 20
Study 33971993 — intervention group
Group type: EXPERIMENTAL
Intervention: Pecan nuts group (30 g/d of pecans + healthy diet)
Number of subjects: 204
Study 33971993 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra-virgin olive oil group (30 ml/d of extra-virgin olive oil + healthy diet)
Number of subjects: 204
Study 33971993 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy diet)
Number of subjects: 204
Study 32436318 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulforaphane (SFN)
Number of subjects: 300
Study 32436318 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 32833851 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided intermediate cervical plexus block (Group-1) with 10ml of 0.5% bupivacaine
Number of subjects: 50
Study 32833851 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided superficial cervical plexus block (Group-2) with 10ml of 0.5% bupivacaine
Number of subjects: 50
Study 32833851 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided intermediate cervical plexus block (Group-1)
Number of subjects: 50
Study 32833851 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided superficial cervical plexus block (Group-2)
Number of subjects: 50